The Improving ATTENDance in Cardiac Rehabilitation Trial



Status:Recruiting
Conditions:Angina, Angina, Peripheral Vascular Disease, Cardiology, Cardiology, Cardiology, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - 85
Updated:2/27/2019
Start Date:March 1, 2019
End Date:July 31, 2023
Contact:Crystal Grimshaw
Email:cgrimsh1@hfhs.org
Phone:313-972-4037

Use our guide to learn which trials are right for you!

The benefits of cardiac rehabilitation are well known. However, despite center based cardiac
rehabilitation (CBCR) representing guideline-based care for patients with cardiovascular
disease, most patients do not complete the maximum number of sessions allowed by third party
insurance payers. As such, many patients may not be receiving the full clinical benefit
ascribed to CR. This study will assess the efficacy of an innovative approach to CR delivery
on attendance by combining both center-based and remote- or home-based CR sessions. The
intervention group combines center-based CR and remote-/home-based CR and is tailored to the
individual needs of each patient, accomplished with the assistance of an easy-to-access
telecommunications methodology (telemedicine)


Inclusion Criteria:

1. Has agreed to participate in CR and has experienced a cardiac event (myocardial
infraction, coronary revascularization, heart valve surgery, or cardiac transplant in
the past 6 months; diagnosed with chronic, stable AHA/ACC stage B or C heart failure
or Canadian class 0-2 stable angina pectoris)

2. Lives in or plans to remain in the greater Detroit, MI area for the next year

3. Age 18-85 years of age

4. Agrees to attend at least one CBCR session

5. Agrees to scheduling at least 2, up to 3, CR sessions (either CBCR or HYCR)/wk

6. Has demonstrated to research staff their ability to access and connect to the internet
via smart phone or tablet and already has access to satisfactory home- or
community-based exercise equipment

Exclusion Criteria:

1. Received a left ventricular assist device, receiving continuous inotropic support
(e.g., milrinone), or undergoing hemodialysis

2. Angina at rest or with a low functional capacity (< 2 METs)

3. Advanced cancer, advanced risk for falling, limiting cognitive impairment, or other
advanced disorder that limits participation in CR

1. Advanced risk for falling will be assessed by 5X sit-to-stand test, with a
cut-off score of >15 seconds

2. Cognitive assessment will be completed using the Mini-Cog instrument, with a
cut-off score < 3 used to exclude potential subjects.

4. Severe arrhythmia unless adequately treated (e.g., implantable cardiac defibrillator)

5. Pregnant or plan to become pregnant in the next year.

6. Major cardiovascular procedure or hospitalization planned in the next 6 months

7. Less than 12 month life expectancy

8. Participation in another clinical trial that interferes with iATTEND participation,
follow-up, data collection, exercise capacity or quality of life.
We found this trial at
1
site
Detroit, Michigan 48202
?
mi
from
Detroit, MI
Click here to add this to my saved trials